TMEFF2 and gastric cancer: Sun et al. [42] presented similar findings in gastric cancer where TMEFF2 was notably expressed in 44.6% of normal gastric epithelium, 29.2% of intestinal metaplasia, 18.5% of dysplasia and 7.7% of gastric cancer.